share_log

HC Wainwright & Co. Reiterates Buy on AC Immune, Maintains $16 Price Target

Benzinga ·  Aug 7, 2023 06:12

HC Wainwright & Co. analyst Andrew Fein reiterates AC Immune (NASDAQ:ACIU) with a Buy and maintains $16 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment